Is It Possible to Prevent Acute Kidney Injury in Patients Who Underwent Contrast Medium?

Abstract

Get full access to this article

View all access options for this article.

References

Alharazy

Kong

Saidin

. Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography. Angiology. 2014;65(3):216–223.

Ishibashi

Yamauchi

Musha

Mikami

Kawasaki

Miyake

. Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization. Angiology. 2010;61(8):724–730.

Athyros

Katsiki

Karagiannis

Mikhailidis

. Stage of chronic kidney disease and severity of coronary heart disease manifestation. Expert Opin Pharmacother. 2012;13(4):457–460.

Yang

. Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention. Angiology. 2013;64(3):188–194.

Markota

Starcevic

Tomic

Prskalo

Brizic

. Prevention of contrast-induced nephropathy with Na/K citrate [published online January 24, 2013]. Eur Heart J. 2013.

Chang

Yang

Lin

Chung

. Gene polymorphisms of interleukin-10 and tumor necrosis factor-alpha are associated with contrast-induced nephropathy. Am J Nephrol. 2013;37(2):110–117.